|
Market Closed -
Nasdaq
23:00:00 22/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.020 USD | -1.23% |
|
-12.61% | -72.98% |
| 08-14 | Seres Therapeutics Files $300 Million Mixed Shelf | MT |
| 08-05 | Seres Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SERES THERAPEUTICS, INC. | Bio Therapeutic Drugs | -1.23% | -12.61% | -72.98% | -75.67% | -97.14% | 39.96M |  | | |
- Stock Market
- Stocks
- MCRB Stock
- Charts Seres Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
